Clinical Research Directory
Browse clinical research sites, groups, and studies.
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
Sponsor: Connecticut Children's Medical Center
Summary
The rationale for fetal therapy in severe congenital diaphragmatic hernia (CDH) is to restore adequate lung growth for neonatal survival.
Official title: Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2015-09
Completion Date
2030-08
Last Updated
2025-05-15
Healthy Volunteers
No
Conditions
Interventions
Fetoscopic Endoluminal Tracheal Occlusion (FETO)
This study will position and remove an endoluminal tracheal balloon in utero (FETO) to study the feasibility of implementing FETO therapy in the most severe group of fetuses with left CDH and observed/expected length head ratio \<25% (O/E LHR).
Locations (1)
Connecticut Children's Medical Center
Hartford, Connecticut, United States